• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

204 个国家和地区 1990 年至 2019 年慢性淋巴细胞白血病的全球负担及归因风险因素:基于 2019 年全球疾病负担研究的分析。

The global burden and attributable risk factors of chronic lymphocytic leukemia in 204 countries and territories from 1990 to 2019: analysis based on the global burden of disease study 2019.

机构信息

Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, 79 Qingchun Road, Hangzhou, Zhejiang, 310003, People's Republic of China.

Zhejiang Provincial Key Lab of Hematopoietic Malignancy, Zhejiang University, Hangzhou, Zhejiang, 310003, People's Republic of China.

出版信息

Biomed Eng Online. 2022 Jan 11;21(1):4. doi: 10.1186/s12938-021-00973-6.

DOI:10.1186/s12938-021-00973-6
PMID:35016695
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8753864/
Abstract

BACKGROUND

Chronic lymphocytic leukemia (CLL) is the most prevalent subtype of leukemia in Western countries, causing a substantial health burden on patients and society. Comprehensive evaluation of the epidemiological characteristics of CLL is warranted, especially in the current context of global population aging. The main objective of this study is evaluating the disease burden of CLL at global, regional, and national levels from 1990 to 2019. As secondary objectives, we studied the influence of demographic factors and performed risk factor analysis. We hope this study could provide evidence for the evaluation of the effectiveness of previous prevention strategies and the formulation of future global health policies.

RESULTS

Based on data of CLL between 1990 to 2019 from the Global Burden of Disease (GBD) study 2019, we depicted the age, gender, and regional structure of the CLL burden population and described the impact of social development on the disease burden of CLL. The distribution and changing trends of attributable risk factors were also investigated. The global burden of CLL has increased dramatically. A high incidence has been achieved in males and elder people. Countries and territories with high social-demographic index (SDI) tended to have higher global burden than low-SDI region. Of risk factors, high body mass index and smoking were the major contributors for CLL-related mortality and disability adjusted life-years (DALYs).

CONCLUSION

In summary, the global CLL burden continues to rise over the past 30 years. The relocation of medical resource should be considered on a global scale.

摘要

背景

慢性淋巴细胞白血病(CLL)是西方国家最常见的白血病亚型,给患者和社会带来了巨大的健康负担。有必要全面评估 CLL 的流行病学特征,尤其是在当前全球人口老龄化的背景下。本研究的主要目的是评估 1990 年至 2019 年全球、区域和国家层面 CLL 的疾病负担。作为次要目标,我们研究了人口因素的影响并进行了危险因素分析。我们希望本研究能为评估以往预防策略的效果和制定未来全球卫生政策提供依据。

结果

基于 2019 年全球疾病负担(GBD)研究中 1990 年至 2019 年 CLL 的数据,我们描述了 CLL 负担人群的年龄、性别和区域结构,并描述了社会发展对 CLL 疾病负担的影响。还调查了归因危险因素的分布和变化趋势。CLL 的全球负担显著增加。男性和老年人的发病率较高。社会人口指数(SDI)较高的国家和地区的全球负担往往高于 SDI 较低的地区。在危险因素中,高体重指数和吸烟是导致 CLL 相关死亡和伤残调整生命年(DALYs)的主要因素。

结论

总之,过去 30 年来,全球 CLL 负担持续上升。应该在全球范围内考虑医疗资源的重新配置。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac17/8753864/b41d50badaf0/12938_2021_973_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac17/8753864/1f492ba374dc/12938_2021_973_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac17/8753864/4193ac910f64/12938_2021_973_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac17/8753864/f11e5c93240f/12938_2021_973_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac17/8753864/fdb20ca37729/12938_2021_973_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac17/8753864/d27ccea795a7/12938_2021_973_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac17/8753864/ce2ed191bfbc/12938_2021_973_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac17/8753864/b41d50badaf0/12938_2021_973_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac17/8753864/1f492ba374dc/12938_2021_973_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac17/8753864/4193ac910f64/12938_2021_973_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac17/8753864/f11e5c93240f/12938_2021_973_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac17/8753864/fdb20ca37729/12938_2021_973_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac17/8753864/d27ccea795a7/12938_2021_973_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac17/8753864/ce2ed191bfbc/12938_2021_973_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac17/8753864/b41d50badaf0/12938_2021_973_Fig7_HTML.jpg

相似文献

1
The global burden and attributable risk factors of chronic lymphocytic leukemia in 204 countries and territories from 1990 to 2019: analysis based on the global burden of disease study 2019.204 个国家和地区 1990 年至 2019 年慢性淋巴细胞白血病的全球负担及归因风险因素:基于 2019 年全球疾病负担研究的分析。
Biomed Eng Online. 2022 Jan 11;21(1):4. doi: 10.1186/s12938-021-00973-6.
2
The global burden and attributable risk factor analysis of acute myeloid leukemia in 195 countries and territories from 1990 to 2017: estimates based on the global burden of disease study 2017.全球 195 个国家和地区 1990 年至 2017 年急性髓系白血病的全球负担和归因风险因素分析:基于 2017 年全球疾病负担研究的估计。
J Hematol Oncol. 2020 Jun 8;13(1):72. doi: 10.1186/s13045-020-00908-z.
3
Smoking prevalence and attributable disease burden in 195 countries and territories, 1990-2015: a systematic analysis from the Global Burden of Disease Study 2015.1990-2015 年 195 个国家和地区的吸烟流行率和可归因疾病负担:来自 2015 年全球疾病负担研究的系统分析。
Lancet. 2017 May 13;389(10082):1885-1906. doi: 10.1016/S0140-6736(17)30819-X. Epub 2017 Apr 5.
4
Trends in Disease Burden of Chronic Lymphocytic Leukemia at the Global, Regional, and National Levels From 1990 to 2019, and Projections Until 2030: A Population-Based Epidemiologic Study.1990年至2019年全球、区域和国家层面慢性淋巴细胞白血病疾病负担趋势及至2030年的预测:一项基于人群的流行病学研究
Front Oncol. 2022 Mar 10;12:840616. doi: 10.3389/fonc.2022.840616. eCollection 2022.
5
The global burden of disease attributable to high body mass index in 195 countries and territories, 1990-2017: An analysis of the Global Burden of Disease Study.2019 年全球 195 个国家和地区因超重导致的疾病负担:基于全球疾病负担研究的分析。
PLoS Med. 2020 Jul 28;17(7):e1003198. doi: 10.1371/journal.pmed.1003198. eCollection 2020 Jul.
6
Global disease burden and trends of leukemia attributable to occupational risk from 1990 to 2019: An observational trend study.全球疾病负担与 1990 年至 2019 年归因于职业风险的白血病趋势:一项观察性趋势研究。
Front Public Health. 2022 Nov 14;10:1015861. doi: 10.3389/fpubh.2022.1015861. eCollection 2022.
7
The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.195 个国家和地区 1990-2017 年食管痛的全球、区域和国家负担及其可归因风险因素:2017 年全球疾病负担研究的系统分析。
Lancet Gastroenterol Hepatol. 2020 Jun;5(6):582-597. doi: 10.1016/S2468-1253(20)30007-8. Epub 2020 Apr 1.
8
Measuring the global disease burden of polycystic ovary syndrome in 194 countries: Global Burden of Disease Study 2017.测量 194 个国家多囊卵巢综合征的全球疾病负担:2017 年全球疾病负担研究。
Hum Reprod. 2021 Mar 18;36(4):1108-1119. doi: 10.1093/humrep/deaa371.
9
Epidemiological trends of tracheal, bronchus, and lung cancer at the global, regional, and national levels: a population-based study.全球、区域和国家层面气管、支气管和肺癌的流行病学趋势:一项基于人群的研究。
J Hematol Oncol. 2020 Jul 20;13(1):98. doi: 10.1186/s13045-020-00915-0.
10
The global, regional, and national burden of stomach cancer in 195 countries, 1990-2017: a systematic analysis for the Global Burden of Disease study 2017.全球、地区和国家 195 个国家/地区 1990-2017 年胃癌负担:2017 年全球疾病负担研究的系统分析。
Lancet Gastroenterol Hepatol. 2020 Jan;5(1):42-54. doi: 10.1016/S2468-1253(19)30328-0. Epub 2019 Oct 21.

引用本文的文献

1
Real-World Outcomes with Orelabrutinib in Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Retrospective Study.奥布替尼治疗慢性淋巴细胞白血病/小淋巴细胞淋巴瘤患者的真实世界疗效:一项回顾性研究
Adv Ther. 2025 Sep 3. doi: 10.1007/s12325-025-03344-y.
2
The Role of Tumor Microenvironment and Targeted Therapy in Chronic Lymphocytic Leukemia.肿瘤微环境与靶向治疗在慢性淋巴细胞白血病中的作用
Curr Issues Mol Biol. 2025 Aug 1;47(8):604. doi: 10.3390/cimb47080604.
3
Genetic background of Richter transformation of atypical chronic lymphocytic leukemia to diffuse large B-cell lymphoma - a case study.

本文引用的文献

1
Global, regional, and national burdens of leukemia from 1990 to 2017: a systematic analysis of the global burden of disease 2017 study.全球、地区和国家白血病负担:2017 年全球疾病负担研究的系统分析。
Aging (Albany NY). 2021 Apr 4;13(7):10468-10489. doi: 10.18632/aging.202809.
2
Impact of Oral Targeted Therapy on the Economic Burden of Chronic Lymphocytic Leukemia in Canada.加拿大口服靶向治疗对慢性淋巴细胞白血病经济负担的影响。
Curr Oncol. 2021 Jan 9;28(1):332-345. doi: 10.3390/curroncol28010037.
3
Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.
非典型慢性淋巴细胞白血病转化为弥漫性大B细胞淋巴瘤的Richter转化的遗传背景——一项病例研究
J Appl Genet. 2025 Aug 9. doi: 10.1007/s13353-025-00999-9.
4
Comparative analysis of patients' characteristics, treatment, and survival outcomes in CLL from China and the United States.中国和美国慢性淋巴细胞白血病患者特征、治疗及生存结局的比较分析。
Oncologist. 2025 Jul 4;30(7). doi: 10.1093/oncolo/oyaf181.
5
Global, regional, and national burden of leukemia: Epidemiological trends analysis from 1990 to 2021.全球、区域和国家白血病负担:1990年至2021年的流行病学趋势分析
PLoS One. 2025 Jun 26;20(6):e0325937. doi: 10.1371/journal.pone.0325937. eCollection 2025.
6
High-intensity interval training and strength conditioning in patients with chronic lymphocytic leukemia: a systematic review.慢性淋巴细胞白血病患者的高强度间歇训练和力量训练:一项系统综述
Syst Rev. 2025 May 23;14(1):116. doi: 10.1186/s13643-025-02764-9.
7
Ibrutinib enhances the bias of T cell responses towards staphylococcal superantigens sustaining inflammation in chronic lymphocytic leukaemia.依鲁替尼增强了T细胞对葡萄球菌超抗原的反应偏向性,从而维持慢性淋巴细胞白血病中的炎症。
Front Immunol. 2025 Mar 26;16:1531059. doi: 10.3389/fimmu.2025.1531059. eCollection 2025.
8
Screening and identification analysis of core markers for leukemia and cervical cancer: Calmodulin 3 as a core target.白血病和宫颈癌核心标志物的筛选与鉴定分析:钙调蛋白3作为核心靶点
Medicine (Baltimore). 2025 Apr 4;104(14):e41665. doi: 10.1097/MD.0000000000041665.
9
Building a new score system for the diagnosis and differential diagnosis of typical CLL/SLL, atypical CLL/SLL, and MCL based on the flow cytometry immunophenotyping.基于流式细胞术免疫表型分析建立用于典型慢性淋巴细胞白血病/小淋巴细胞淋巴瘤、非典型慢性淋巴细胞白血病/小淋巴细胞淋巴瘤和套细胞淋巴瘤诊断及鉴别诊断的新评分系统。
Ann Hematol. 2025 Mar;104(3):1807-1819. doi: 10.1007/s00277-025-06231-2.
10
Upfront fixed-duration treatment strategies for chronic lymphocytic leukemia in Arab populations: a position statement from the Gulf region.阿拉伯人群慢性淋巴细胞白血病的初始固定疗程治疗策略:海湾地区的立场声明
Front Med (Lausanne). 2025 Feb 26;12:1509074. doi: 10.3389/fmed.2025.1509074. eCollection 2025.
204 个国家和地区 1990-2019 年 369 种疾病和伤害导致的全球负担:2019 年全球疾病负担研究的系统分析。
Lancet. 2020 Oct 17;396(10258):1204-1222. doi: 10.1016/S0140-6736(20)30925-9.
4
Five insights from the Global Burden of Disease Study 2019.2019 年全球疾病负担研究的五个洞见。
Lancet. 2020 Oct 17;396(10258):1135-1159. doi: 10.1016/S0140-6736(20)31404-5.
5
Leukemia incidence trends at the global, regional, and national level between 1990 and 2017.1990年至2017年间全球、区域和国家层面的白血病发病率趋势。
Exp Hematol Oncol. 2020 Jun 19;9:14. doi: 10.1186/s40164-020-00170-6. eCollection 2020.
6
The global burden and attributable risk factor analysis of acute myeloid leukemia in 195 countries and territories from 1990 to 2017: estimates based on the global burden of disease study 2017.全球 195 个国家和地区 1990 年至 2017 年急性髓系白血病的全球负担和归因风险因素分析:基于 2017 年全球疾病负担研究的估计。
J Hematol Oncol. 2020 Jun 8;13(1):72. doi: 10.1186/s13045-020-00908-z.
7
Real-World Treatment Patterns, Adverse Events, Resource Use, and Costs Among Commercially Insured, Younger Patients with Chronic Lymphocytic Leukemia in the USA: A Retrospective Cohort Study.美国商业保险覆盖的年轻慢性淋巴细胞白血病患者的真实世界治疗模式、不良事件、资源利用和成本:一项回顾性队列研究。
Adv Ther. 2020 Jul;37(7):3129-3148. doi: 10.1007/s12325-020-01350-w. Epub 2020 May 12.
8
Treatment of relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma with the BTK inhibitor zanubrutinib: phase 2, single-arm, multicenter study.泽布替尼治疗复发/难治性慢性淋巴细胞白血病/小淋巴细胞淋巴瘤的疗效:一项 2 期、单臂、多中心研究。
J Hematol Oncol. 2020 May 11;13(1):48. doi: 10.1186/s13045-020-00884-4.
9
Colorectal cancer statistics, 2020.2020 年结直肠癌统计数据。
CA Cancer J Clin. 2020 May;70(3):145-164. doi: 10.3322/caac.21601. Epub 2020 Mar 5.
10
The disease burden attributable to 18 occupational risks in China: an analysis for the global burden of disease study 2017.中国 18 种职业风险相关疾病负担:2017 年全球疾病负担研究分析。
Environ Health. 2020 Feb 19;19(1):21. doi: 10.1186/s12940-020-00577-y.